Drug intelligence / Profile preview

yiqi gubiao pill

Development stage
Phase 1
Lead developer
Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University
Administration
Oral
01

Overview

Yiqi Gubiao Pill is a Traditional Chinese Medicine (TCM) formulation primarily developed and investigated by the Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital (also known as the Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University). The formula is designed to treat respiratory conditions by addressing "lung-spleen qi deficiency" (Fei-Pi Qi-Deficiency Syndrome), a common TCM pattern in chronic lung diseases. It is used to treat stable Chronic Obstructive Pulmonary Disease (COPD), Tuberculosis-related obstructive pulmonary disease (TOPD), and allergic rhinitis. Clinical studies, including Phase II randomized controlled trials, have demonstrated its potential in relieving cough, alleviating asthma, expectorating phlegm, and delaying airway obstruction. The formulation is available in several forms, including traditional pills, condensed pills, and granules.

Brand names
Yiqigubiao pillYiqi Gubiao Pills益气固表丸
Other names
Yiqi Gubiao WanYiqi Gubiao GranuleYiqi Gubiao Condensed PillYiqigubiao Pill益气固表丸益气固表颗粒益气固表浓缩丸
02

Targets

SIRT5 (NAD-dependent protein deacylase sirtuin-5, mitochondrial)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on yiqi gubiao pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yiqi gubiao pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call